What is Veradermics 's financing cash flow?

Veradermics (MANE) reported financing cash flow of $269.11M in Q1 2026.

What does financing cash flow mean?

The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.

Financing

Financing Cash Flow

Veradermics Financing Cash Flow increased by 3095.0% to $269.11M in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement

SectionFinancing

CategoryCapital Allocation

SignalContext dependent

VolatilityModerate

First reportedQ1 2013

Last reportedQ1 2026

How to read this metric

A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.

Detailed definition

This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...

Peer comparison

Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.

Metric ID: cf_net_cash_from_financing

Historical Data

2 periods

	Q1 '25	Q1 '26
Value	$8.42M	$269.11M
QoQ Change	—	>999%
YoY Change	—	>999%

Range$8.42M – $269.11M

Avg YoY Growth>999%

Median YoY Growth>999%

Frequently Asked Questions

What is Veradermics 's financing cash flow?: Veradermics (MANE) reported financing cash flow of $269.11M in Q1 2026.
What does financing cash flow mean?: The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.